Comtan (entacapone), a new drug for advanced Parkinson's disease

December 1999

Novartis is now introducing Comtan (entacapone), a new drug for advanced Parkinson's disease.

It's given to enhance the effectiveness of levodopa/carbidopa (Sinemet, etc).

Comtan is a COMT inhibitor...in the same class as Tasmar (tolcapone). But Comtan isn't expected to have the same problems with liver toxicity.

Practical advice for a better career, with unlimited access to CE

Pharmacy Technician's Letter includes:

12 issues every year, with brief articles about new meds and hot topics
120+ CE courses, including the popular CE-in-the-Letter
Helpful, in-depth Technician Tutorials
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Table of Contents

highlighting the value of pharmacists' interventions
whether patients on SSRIs can use one of the "triptans" for migraines
Comtan (entacapone), a new drug for advanced Parkinson's disease
Diabetes many patients with type 1 diabetes don't realize when their blood sugar is too low to drive safely
Women's Health estrogen replacement therapy reduces the risk of colorectal cancer
Women's Health PremesisRx, a new prescription product for morning sickness
Ophthalmology more people taking lutein
Infectious Diseases two new flu drugs, Tamiflu (oseltamivir) and Relenza (zanamivir)
Infectious Diseases Do all the new antibacterial soaps, lotions, and gels really help prevent colds and flu
Rheumatoid Arthritis Enbrel (etanercept) or Remicade (infliximab) for rheumatoid arthritis
natural products for the cold and flu season
Cardiology low-molecular-weight heparins
Cardiology amiodarone (Cordarone IV) to help resuscitate cardiac arrest victims
Lots of people are using magnets
Practice taking their quinolone antibiotic, Raxar (grepafloxacin) off the market